<DOC>
	<DOC>NCT02819609</DOC>
	<brief_summary>The purpose of this observational, retrospective database study of patients with uterine fibroids is to compare the durability of symptom relief after uterus-conserving treatments for symptomatic fibroids in terms of incidence of, and time to, new or recurrent symptoms and subsequent procedures and evaluate the effect stakeholder participation had on the research process.</brief_summary>
	<brief_title>Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Female patients with a diagnosis of uterine fibroids at any time and at least 1 office visit during study time period At least 1 of the procedures of interest occurring between January 1, 2005 December 31, 2011 â‰¥ 18 years and &lt; 55 years of age at the index date Patients with a diagnosis of gynecologic cancer (ovarian, uterine, cervical) First recorded diagnosis of uterine fibroids occurring beyond four weeks after the Index Date ONLY for patients who underwent endometrial ablation or hysterectomy Patients with a record of any procedures of interest occurring before January 1, 2005</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>